The phosphodiesterase inhibitor pentoxifylline reduces early side effects of interferon-beta 1b treatment in patients with multiple sclerosis.
Rieckmann
P
P
Department of Neurology, Georg-August-University, Göttingen, Germany.
Weber
F
F
Günther
A
A
Poser
S
S
D006801:Humans; D016899:Interferon-beta / Q000009:adverse effects*; D009103:Multiple Sclerosis / Q000188:drug therapy*; D010431:Pentoxifylline / Q000627:therapeutic use*
D016899:Interferon-beta; D010431:Pentoxifylline